ABCG2 and colorectal carcinoma: Inhibiting MDR1, MRP1, BCRP and ABC transporters, along with silencing MALAT1 and overexpressing miR‐20b‐5p, collectively suppressed CRC growth and metastasis while enhancing the susceptibility of CRC cell lines to 5‐FU.